These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34536214)

  • 1. Public Health Measures and the Control of COVID-19 in China.
    Cheng ZJ; Zhan Z; Xue M; Zheng P; Lyu J; Ma J; Zhang XD; Luo W; Huang H; Zhang Y; Wang H; Zhong N; Sun B
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):1-16. PubMed ID: 34536214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Containment: Comparisons and Suggestions for Global Response.
    Cheng S; Zhao Y; Kaminga AC; Wang X; Zhang X; Xu H
    Inquiry; 2022; 59():469580221086142. PubMed ID: 35584986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 4. Confronting COVID-19 and Prioritizing Aging Population.
    Su B; Luo Y; Tian Y; Chen C; Zheng X
    China CDC Wkly; 2023 Mar; 5(10):229-233. PubMed ID: 37006442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.
    Ding D; Zhang R
    Front Public Health; 2022; 10():857003. PubMed ID: 35359767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental management strategy in response to COVID-19 in China: Based on text mining of government open information.
    Kang A; Ren L; Hua C; Song H; Dong M; Fang Z; Zhu M
    Sci Total Environ; 2021 May; 769():145158. PubMed ID: 33485207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Country Comparison of Public Awareness, Rumors, and Behavioral Responses to the COVID-19 Epidemic: Infodemiology Study.
    Hou Z; Du F; Zhou X; Jiang H; Martin S; Larson H; Lin L
    J Med Internet Res; 2020 Aug; 22(8):e21143. PubMed ID: 32701460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to the COVID-19 Pandemic: Comparison of Strategies in Six Countries.
    Chen H; Shi L; Zhang Y; Wang X; Jiao J; Yang M; Sun G
    Front Public Health; 2021; 9():708496. PubMed ID: 34660510
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Zhou L; Wu Z; Li Z; Zhang Y; McGoogan JM; Li Q; Dong X; Ren R; Feng L; Qi X; Xi J; Cui Y; Tan W; Shi G; Wu G; Xu W; Wang X; Ma J; Su X; Feng Z; Gao GF
    Clin Infect Dis; 2021 Jan; 72(2):332-339. PubMed ID: 33501949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China's global engagement to fight the novel coronavirus pandemic.
    Song W
    Glob Health Res Policy; 2020; 5():44. PubMed ID: 33083550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.
    Lu G; Cao Y; Zhang D; Zhang Y; Xu Y; Lu Y; Chen Q; Zhu G; Yan J; Müller O; Cao J
    Global Health; 2022 Jun; 18(1):64. PubMed ID: 35729642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to COVID-19 in the Central African Republic: Coping Strategies Combined With China's Experience.
    Gou Q; Zhu F; Xie K; Li Y; Xie Y
    Int J Public Health; 2022; 67():1604344. PubMed ID: 35548685
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Epidemic and Public Health Measures in China.
    Xu T; Yang R
    J Epidemiol Glob Health; 2020 Jun; 10(2):118-123. PubMed ID: 32538026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between two types of control strategies for the coronavirus disease 2019 pandemic.
    Zhang X; Wang Y
    J Infect Dev Ctries; 2020 Jul; 14(7):696-698. PubMed ID: 32794456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience and thinking on the normalization stage of prevention and control of COVID-19 in China].
    Liang WN; Yao JH; Wu J; Liu X; Liu J; Zhou L; Chen C; Wang GF; Wu ZY; Yang WZ; Liu M
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):695-699. PubMed ID: 33498104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.